Bancroft Robert E.
SEC insider (Form 3/4/5 filer). CIK 0002066370. PRESIDENT & CEO at AEON Biopharma, Inc. (AEON). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 17, 2026. Located in IRVINE, CA.
Companies Bancroft Robert E. has filed insider reports for
- AEON Biopharma, Inc. (AEON): Director, Officer, PRESIDENT & CEO
Bancroft Robert E.
CIK: 0002066370
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AEON
AEON Biopharma, Inc.
DirectorOfficer